PRME Receives FDA RMAT Designation
Prime Medicine receives U.S. FDA Regenerative Medicine Advanced Therapy designation for PM359 to treat Chronic Granulomatous Disease
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.